Aashish Vyas

964 total citations
16 papers, 611 citations indexed

About

Aashish Vyas is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Speech and Hearing. According to data from OpenAlex, Aashish Vyas has authored 16 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 2 papers in Speech and Hearing. Recurrent topics in Aashish Vyas's work include Respiratory and Cough-Related Research (10 papers), Asthma and respiratory diseases (8 papers) and Voice and Speech Disorders (6 papers). Aashish Vyas is often cited by papers focused on Respiratory and Cough-Related Research (10 papers), Asthma and respiratory diseases (8 papers) and Voice and Speech Disorders (6 papers). Aashish Vyas collaborates with scholars based in United Kingdom, Canada and Hong Kong. Aashish Vyas's co-authors include Robert Niven, B. Ronan O’Driscoll, Julie Morris, Georgina Powell, David W. Denning, Graham T. Atherton, Stephen J. Fowler, Anna MacPherson, Catherine Walshe and Jemma Haines and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Aashish Vyas

15 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aashish Vyas United Kingdom	10	291	285	117	98	72	16	611
Marie‐Kathrin Breyer Austria	14	369 1.3×	458 1.6×	99 0.8×	74 0.8×	13 0.2×	41	817
Robab Breyer‐Kohansal Austria	13	369 1.3×	407 1.4×	100 0.9×	57 0.6×	26 0.4×	47	800
Mutasim Abu‐Hasan United States	14	394 1.4×	420 1.5×	16 0.1×	21 0.2×	31 0.4×	52	678
Lütfi Çöplü Türkiye	17	177 0.6×	662 2.3×	25 0.2×	68 0.7×	35 0.5×	81	877
Yıldız Dallar Türkiye	14	56 0.2×	69 0.2×	90 0.8×	72 0.7×	13 0.2×	79	650
İlknur Bostancı Türkiye	12	130 0.4×	68 0.2×	103 0.9×	40 0.4×	142 2.0×	89	512
Luis Fernando Giraldo‐Cadavid Colombia	10	138 0.5×	300 1.1×	61 0.5×	19 0.2×	12 0.2×	66	643
Daniel Laskey United States	5	401 1.4×	185 0.6×	25 0.2×	4 0.0×	72 1.0×	17	705
Peter Van Asperen Australia	18	278 1.0×	700 2.5×	52 0.4×	5 0.1×	27 0.4×	37	861
Arth Nana Thailand	18	188 0.6×	477 1.7×	27 0.2×	170 1.7×	11 0.2×	49	826

Countries citing papers authored by Aashish Vyas

Since Specialization

Citations

This map shows the geographic impact of Aashish Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aashish Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aashish Vyas more than expected).

Fields of papers citing papers by Aashish Vyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aashish Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aashish Vyas. The network helps show where Aashish Vyas may publish in the future.

Co-authorship network of co-authors of Aashish Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Aashish Vyas. A scholar is included among the top collaborators of Aashish Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aashish Vyas. Aashish Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Pfeffer, Paul, Thomas Brown, Rekha Chaudhuri, et al.. (2024). Impact of comorbidities on EQ-5D quality-of-life index in severe asthma. SHILAP Revista de lepidopterología. 3(3). 100286–100286.

Yang, Freda, John Busby, Liam G. Heaney, et al.. (2021). Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry. The Journal of Allergy and Clinical Immunology In Practice. 9(7). 2691–2701.e1. 14 indexed citations

Gallagher, Andrew, Parameswaran Nair, Aashish Vyas, et al.. (2021). Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma. Cochrane Database of Systematic Reviews. 2021(10). CD012929–CD012929. 17 indexed citations

Haines, Jemma, Adel Mansur, Aashish Vyas, et al.. (2020). UK consensus statement on the diagnosis of inducible laryngeal obstruction in light of the COVID‐19 pandemic. Clinical & Experimental Allergy. 50(12). 1287–1293. 6 indexed citations

Wilson, Mathew G, James H. Hull, John Rogers, et al.. (2020). Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. British Journal of Sports Medicine. 54(19). 1157–1161. 135 indexed citations

Mehdi, Syed, Stephen J Milan, Steven Dodd, et al.. (2019). Speech and language therapy for management of chronic cough. Cochrane Database of Systematic Reviews. 2019(7). CD013067–CD013067. 25 indexed citations

Vyas, Aashish, et al.. (2019). Heliox for inducible laryngeal obstruction (vocal cord dysfunction): A systematic literature review. Laryngoscope Investigative Otolaryngology. 4(2). 255–258. 9 indexed citations

Gallagher, Andrew, et al.. (2018). Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews. 2 indexed citations

Mehdi, Syed, et al.. (2018). Speech and language therapy for management of chronic cough. Cochrane Database of Systematic Reviews. 17 indexed citations

10.

Haines, Jemma, et al.. (2016). Impact of respiratory speech and language therapy on symptoms in vocal cord dysfunction. PA4164–PA4164. 2 indexed citations

11.

Vyas, Aashish, et al.. (2015). Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?. Respiratory Medicine. 109(8). 963–969. 59 indexed citations

12.

Alston, Charlotte L., Andrew M. Schaefer, Nicola Solaroli, et al.. (2013). Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions. Neurology. 81(23). 2051–2053. 17 indexed citations

13.

MacPherson, Anna, et al.. (2012). The views of patients with severe chronic obstructive pulmonary disease on advance care planning: A qualitative study. Palliative Medicine. 27(3). 265–272. 58 indexed citations

14.

Haines, Jemma, et al.. (2012). Multidisciplinary Treatment For Vocal Cord Dysfunction: A Case Of Improved Symptom Presentation And Management. A4199–A4199. 1 indexed citations

15.

Haines, Jemma, Stephen J. Fowler, Robin Gore, & Aashish Vyas. (2010). Vocal Cord Dysfunction Presenting Only In Expiration With Normal Inspiratory Vocal Cord Movement. A2757–A2757. 2 indexed citations

16.

Denning, David W., B. Ronan O’Driscoll, Georgina Powell, et al.. (2008). Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization. American Journal of Respiratory and Critical Care Medicine. 179(1). 11–18. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact